Techalt, Inc. Announces that Derek Lowe Credits SRO for Helping His Career

Business Wire, August 25, 2008

SEATTLE -- Techalt, Inc. (PINK SHEETS:TCLT)("Techalt" the "Company") announces that Stan's Rodeo Ointment ("SRO") and Stan's Blister Cream ("SBR") continue to experience success in Major League Baseball ("MLB"). Derek Lowe ("Lowe"), starting pitcher for the MLB team, the Los Angeles Dodgers, for the past 4 years credits SRO and SBR with alleviating a re-occurring thumb blister, which he has suffered from, even prior to joining the Dodgers.

During Spring Training in 2005, Stanley Johnston ("Johnston"), the head athletic trainer of the Dodgers at that time and inventor of the products introduced Lowe to SRO and SBR. Johnston stated, "When Derek arrived in "Dodgertown" (a colloquial name for the Dodger franchise) the first concern he mentioned to me was the thumb blister he developed while with the Boston Red Sox. Lowe's consistent use of SRO and SBR for the past 4 years has allowed him to concentrate on his personal performance without worrying about changing his pitching style due to pain previously caused by the chronic thumb blister."

Lowe elaborated, "I use SBR 3 times a day for the entire preseason and regular season and use SRO when I need it. With SRO & SBR I do not have to worry about getting a blister on my pitching hand so I can concentrate on my craft of pitching and getting people out. Since I have been using it the last four years I have not had a problem that affected the way I pitch. Thanks to these products I know that I can heal things faster than the other conventional means." Lowe has 50 career wins for the Dodgers with over a month left in the 2008 season.

Hong Cho Kuo, a pitcher for the Dodgers who also regularly uses SRO and SBR agrees, stating, "I have been using it [SRO] for 2 years, and it is the only product that heals my problems quickly enough so I do not have to worry about missing any time on my job. I am a huge advocate of Stan's Rodeo Ointment and of Stan's Blister Rub. I would recommend that any athlete or regular citizen use this product [SRO and SBR] to resolve their wound issues."

Techalt now anticipates a full update from SportPharm (the compounder of SRO, FDA licensed distributor, and Subsidiary Compounding arm of HNP Pharmaceuticals) as SportPharm's representatives return from the 2008 Olympic Games in Beijing. This year, SportPharm featured SRO at the Olympic Games. SportPharm prepares and packages all of the medications it dispenses for use by the U.S. Olympic Team (athletes and staff), and compounds a variety of sports-related rubs for use in the treatment of injuries as well.

About Stan's Rodeo Ointment ("SRO"):

SRO is a sports cream product designed to accelerate the healing time for abrasions, lacerations, blisters and other open wounds to the skin, while diminishing the pain that often results from such injuries. Developed by Stanley Johnston, former head athletic trainer for the Los Angeles Dodgers, SRO is currently available by prescription and used by prominent Olympic and professional athletes. Techalt also acquired the rights to develop Stan's Blister Rub ("SBR"), which is a combination of materials that strengthen the skin after it has healed to reduce the likelihood of the reoccurrence of blisters to the applied area. Patent protection has been filed covering the formulations and processing of SRO with the US Patent and Trademark Office. The Company anticipates that a patent will be issued sometime in 2008.

About Techalt:

Techalt is a public holding company dedicated to pursuing acquisition, licensing and financing opportunities with under-valued start-up and mid-stage companies. Techalt focuses on companies undervalued and under the radar screen with innovative or alternative technologies, particularly in the software, communications, environmental and health and wellness sectors.

David Moore, President of Techalt, stated, "The Company is on target to achieve its mission statement of acquiring under-valued performing assets that are ready to scale, coupled with our management skills and the dollars we have arranged to finance these transactions."

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("the Exchange Act"), as such, may involve risks and uncertainties. Forward-looking statements are based upon certain assumptions and describe future plans, strategies and expectations, are generally identifiable by the use of words as "believe," "expect," "intend," "anticipate," "project," or other similar expressions. Forward-looking statements relate to, among other things, future performance, and perceived opportunities in the market and statements regarding the Company's mission and vision. The Company's actual results, performance and achievements may differ materially from the results, performance, and achievements expressed or implied in such forward-looking statements. Additional factors could materially affect these forward-looking statements and/or predictions include, among other things: (1) managing acquisitions and expansion of operations; (2) the ability of the Company to obtaining necessary financing to fund its business plan, including required financing needs (3) the Company's ability to meet the conditions of the Finance Commitment as well as the Financer's ability to maintain its Finance Commitment (5) completing the investigation, acquisition and integration of new business opportunities; (6) complying with federal, state and local government and international regulations; and (7) other factors over which we have little or no control.